Fady Ibraham Malik
EVP Research & Development at Cytokinetics; Director at Rocket Pharmaceuticals. Based in South San Francisco, California.
- Rank
- 10353rd of 14,644
- Companies held
- 2
- Largest holding
- CYTK, 98.6% of total
- Latest SEC filing
- Nov 17, 2026
What the $8.0M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Cytokinetics CYTK Common Stock | Directly | 153,902 | $51.46 | $7.9M | 98.6% | Form 4, Nov 17, 2026 |
| Rocket Pharmaceuticals RCKT Common Stock | Directly | 52,862 | $2.11 | $112K | 1.4% | Form 4, Jun 18, 2026 |
Share counts are the amounts Fady Ibraham Malik reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Open-market trades, last 12 months
| Date | Trade | Company | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Nov 17, 2026 | Sold | CYTK | 3,300 | $51.73 | $171K | View |
| Nov 17, 2026 | Sold | CYTK | 200 | $52.59 | $11K | View |
| Nov 3, 2026 | Sold | CYTK | 3,500 | $62.93 | $220K | View |
| Oct 20, 2026 | Sold | CYTK | 3,500 | $64.01 | $224K | View |
| Oct 6, 2026 | Sold | CYTK | 3,500 | $61.38 | $215K | View |
| Sep 22, 2026 | Sold | CYTK | 3,500 | $68.29 | $239K | View |
| Sep 8, 2026 | Sold | CYTK | 3,500 | $75.46 | $264K | View |
| Aug 18, 2026 | Sold | CYTK | 3,500 | $75.82 | $265K | View |
| Jul 21, 2026 | Sold | CYTK | 3,500 | $80.59 | $282K | View |
| Jul 7, 2026 | Sold | CYTK | 3,500 | $86.62 | $303K | View |
| Jun 23, 2026 | Sold | CYTK | 3,500 | $79.51 | $278K | View |
| Jun 9, 2026 | Sold | CYTK | 3,500 | $67.98 | $238K | View |
| May 19, 2026 | Sold | CYTK | 3,500 | $75.69 | $265K | View |
| May 5, 2026 | Sold | CYTK | 3,500 | $77.37 | $271K | View |
| Apr 21, 2026 | Sold | CYTK | 3,500 | $65.69 | $230K | View |
| Apr 7, 2026 | Sold | CYTK | 1,000 | $64.75 | $65K | View |
| Apr 7, 2026 | Sold | CYTK | 3,500 | $65.21 | $228K | View |
| Mar 17, 2026 | Sold | CYTK | 4,397 | $62.15 | $273K | View |
| Mar 17, 2026 | Sold | CYTK | 7,636 | $62.15 | $475K | View |
| Mar 9, 2026 | Sold | CYTK | 2,907 | $60.72 | $177K | View |
| Dec 16, 2025 | Sold | CYTK | 2,200 | $61.24 | $135K | View |
| Dec 2, 2025 | Sold | CYTK | 2,200 | $63.89 | $141K | View |
| Nov 18, 2025 | Sold | CYTK | 2,200 | $66.45 | $146K | View |
| Nov 4, 2025 | Sold | CYTK | 2,295 | $59.55 | $137K | View |
| Oct 21, 2025 | Sold | CYTK | 2,105 | $58.22 | $123K | View |
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 10350 | Michael Brian Bell Chief Financial Officer, Guardant Health. Palo Alto, CA | $8.0M |
| 10351 | Benjamin Polk Insider, Monster Beverage. Corona, CA | $8.0M |
| 10352 | Adrian Joseph Daws CEO, Hamilton Re, Hamilton Insurance Group | $8.0M |
| 10353 | Fady Ibraham Malik EVP Research & Development, Cytokinetics. South San Francisco, CA | $8.0M |
| 10354 | Deborah L. Dyson Corp. VP, Automatic Data Processing. Roseland, NJ | $8.0M |
| 10355 | Aaron Karczmer EVP, Chief Enterprise Services, PayPal Holdings. San Jose, CA | $8.0M |
| 10356 | James A. Faulconbridge Director, Hawkins. Roseville, MN | $8.0M |
Other Cytokinetics insiders
All CYTK insiders- Robert I. Blum$14.4MPresident & CEO. #6642 overall
- David Cragg$7.9MChief HR & Admin Officer. #10469 overall
- Mark A. Schlossberg$5.3MSVP - Legal & General Counsel. #13845 overall
- Jeffrey Hessekiel$4.8MChief Legal & Admin Officer. #2526 overall
- Brett A. Pletcher$1.7MEVP, Chief Legal Officer. #11108 overall
- Robert E. Landry$421KDirector. #4734 overall
Questions
How much stock does Fady Ibraham Malik own?
Fady Ibraham Malik holds $8,031,336 in listed stock based on SEC filings and current prices, mostly Cytokinetics (CYTK). That ranks 10353rd on the Stock Rich List.
Is this Fady Ibraham Malik's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did Fady Ibraham Malik last buy or sell stock?
The most recent open-market trade on file is a sale of 3,300 CYTK shares on Nov 17, 2026 at $51.73.